Position in APGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$597,522
-$776,214 QoQ
Shares Held
7,099
-61.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FORA Capital, LLC holds $19,737,715 across 20 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,209 | $1,568,065 | |
| 2 | ABVX |
Abivax S.A.
|
11,758 | $1,566,871 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
44,129 | $1,561,725 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
6,364 | $1,557,716 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
27,289 | $1,550,288 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
4,205 | $1,407,791 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,147 | $1,338,740 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
5,408 | $1,303,165 |
All Filings in APGE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $597,522 | 7,099 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,373,736 | 18,200 | Shares | Sole | 2026-02-13 | |
| 2024-09-30 | $398,785 | 6,789 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||